Drug intelligence / Profile preview

hydrocodone bitartrate + acetaminophen + gamma-aminobutyric acid

Development stage
Approved
Lead developer
Physician Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

Hydrocodone bitartrate + acetaminophen + gamma-aminobutyric acid is an oral combination product marketed as **Theracodophen**, developed by Physician Therapeutics for the dietary management of myalgia and of pain and inflammation. The product combines hydrocodone bitartrate and acetaminophen tablets with separate capsules containing gamma-aminobutyric acid as part of a medical food formulation. Pharmacologically, hydrocodone is a small-molecule **mu-opioid receptor agonist** that provides opioid analgesia, while acetaminophen is a non-opioid analgesic and antipyretic with central pain-relieving activity; the gamma-aminobutyric acid component is presented as a nutritional or medical food ingredient rather than as an FDA-approved active pharmaceutical ingredient for these uses. Available information indicates the labeling was not approved by FDA and the product was not found by FDA to be safe and effective.

Brand names
TheracodophenTheracodophen-Low-90Theracodophen-Low90Theracodophen-Low 90Theracodophen-325Theracodophen325Theracodophen 325Theracodophen-650Theracodophen650Theracodophen 650Theracodophen-750Theracodophen750Theracodophen 750
Other names
hydrocodone bitartrate + acetaminophen + gamma-aminobutyric acid
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on hydrocodone bitartrate + acetaminophen + gamma-aminobutyric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocodone bitartrate + acetaminophen + gamma-aminobutyric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call